Literature DB >> 29248059

Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany.

Adam Pilny1, Ansgar Wübker2, Nicolas R Ziebarth3.   

Abstract

To equalize differences in health plan premiums due to differences in risk pools, the German legislature introduced a simple Risk Adjustment Scheme (RAS) based on age, gender and disability status in 1994. In addition, effective 1996, consumers gained the freedom to choose among hundreds of existing health plans, across employers and state-borders. This paper (a) estimates RAS pass-through rates on premiums, financial reserves, and expenditures and assesses the overall RAS impact on market price dispersion. Moreover, it (b) characterizes health plan switchers and investigates their annual and cumulative switching rates over time. Our main findings are based on representative enrollee panel data linked to administrative RAS and health plan data. We show that sickness funds with bad risk pools and high pre-RAS premiums lowered their total premiums by 42 cents per additional euro allocated by the RAS. Consequently, post-RAS, health plan prices converged but not fully. Because switchers are more likely to be white collar, young and healthy, the new consumer choice resulted in more risk segregation and the amount of money redistributed by the RAS increased over time.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adverse selection; D12; Employer-based health insurance; Free health plan choice; German sickness funds; H51; Health plan switching; I11; I13; I18; Risk adjustment; SOEP

Mesh:

Year:  2017        PMID: 29248059     DOI: 10.1016/j.jhealeco.2017.03.009

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  3 in total

1.  The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization.

Authors:  Andreas Schwarting; Heiko Friedel; Elena Garal-Pantaler; Marc Pignot; Xia Wang; Henk Nab; Barnabas Desta; Edward R Hammond
Journal:  Rheumatol Ther       Date:  2021-02-05

2.  Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.

Authors:  Benedikt Fritzsching; Marco Contoli; Celeste Porsbjerg; Sarah Buchs; Julie Rask Larsen; Lisa Elliott; Mercedes Romano Rodriguez; Nick Freemantle
Journal:  Lancet Reg Health Eur       Date:  2021-11-30

3.  Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study.

Authors:  Melissa S Y Thong; Daniela Doege; Linda Weißer; Lena Koch-Gallenkamp; Heike Bertram; Andrea Eberle; Bernd Holleczek; Alice Nennecke; Annika Waldmann; Sylke Ruth Zeissig; Ron Pritzkuleit; Michael Schlander; Hermann Brenner; Volker Arndt
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-13       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.